Trials / Terminated
TerminatedNCT00771368
Reduction of Bacteria in MRSA Positive Ulcers
A Clinical Trial on the Reduction of Bacteria (Including MRSA) in MRSA Positive Ulcers and Lesions
- Status
- Terminated
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Nitric BioTherapeutics, Inc · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if gaseous nitric oxide is effective in the treatement of bacteria in MRSA positive ulcers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nitric Oxide | 1 % Gaseous Nitric Oxide, delivered for 30 minutes daily for 3 consecutive days |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-05-01
- Completion
- 2009-06-01
- First posted
- 2008-10-13
- Last updated
- 2012-01-19
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00771368. Inclusion in this directory is not an endorsement.